A 42-year-old woman from Uttar Pradesh completed 12 months of MDT-MB for lepromatous leprosy 8 weeks ago. She now presents with painful erythematous nodules on her shins, fever, and painful swollen joints. Slit-skin smear remains 2+. What is the most appropriate next step in management?

Explanation

## Post-MDT Lepra Reactions: Recognition and Management **Key Point:** This patient has completed MDT but now presents with systemic inflammatory symptoms (nodules, fever, arthralgia) occurring **within 6 months of completing MDT-MB**. This is **Type 2 lepra reaction (Erythema Nodosum Leprosum, ENL)**, not treatment failure or drug resistance. ### Lepra Reactions: Type 1 vs Type 2 | Feature | Type 1 (Reversal Reaction) | Type 2 (ENL) | |---------|---------------------------|---------------| | **Timing** | During or shortly after MDT | Weeks to months after MDT completion | | **Pathology** | Cell-mediated immunity (Type IV) | Immune complex deposition (Type III) | | **Clinical signs** | Inflammation of existing lesions & nerves | Systemic: nodules, fever, arthralgia, iritis, neuritis | | **Leprosy type** | BT, BL, LL | LL and BL (high bacillary load) | | **Bacillary load** | Variable | Usually high (2–6+) | | **Management** | NSAIDs ± corticosteroids | Corticosteroids (first-line); thalidomide if severe | **High-Yield:** ENL is an **immune reconstitution phenomenon**, not drug failure. It reflects the patient's immune system responding to leprosy antigens. Persistent AFB in smear does not mean treatment failure — dead bacilli can remain AFB-positive for months. ### Diagnostic Algorithm for Post-MDT Symptoms ```mermaid flowchart TD A[Completed MDT-MB 8 weeks ago]:::outcome --> B{New symptoms?}:::decision B -->|Inflammation of existing lesions/nerves| C[Type 1 Reaction]:::outcome B -->|Nodules + fever + systemic signs| D[Type 2 Reaction ENL]:::outcome C --> E[NSAIDs ± prednisolone]:::action D --> F[Prednisolone 0.5-1 mg/kg/day]:::action F --> G{Response in 2-4 weeks?}:::decision G -->|Yes| H[Taper prednisolone over 3 months]:::action G -->|No| I[Add thalidomide 100-300 mg/day]:::action ``` **Clinical Pearl:** The presence of AFB 2+ in slit-skin smear **8 weeks post-MDT does not indicate treatment failure**. Bacilli take 3–6 months to clear from tissues. What matters is the **clinical response** (lesion flattening, nerve function recovery). ENL is a complication of successful treatment, not failure. **Mnemonic: ENL-SIF** — Erythema Nodosum Leprosum occurs in LL and BL; Systemic inflammation (nodules, fever, iritis); Immune complex reaction; Follows completion of MDT. ### Why This Is ENL, Not Treatment Failure 1. **Timing:** 8 weeks post-MDT completion (classic for ENL) 2. **Systemic symptoms:** Fever, nodules, arthralgia = immune complex deposition 3. **AFB persistence:** Expected; does not indicate drug resistance 4. **Leprosy type:** LL has high risk of ENL post-MDT 5. **No new lesions:** Patient is not relapsing; existing disease is inflaming **Tip:** Do not restart MDT or add fluoroquinolones. The patient is already cured bacteriologically. Manage the inflammatory reaction with corticosteroids. Monitor for complications (iritis, neuritis, orchitis).